Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial

Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New recruitment locations have been added (for example Atakum VM Medical Park Samsun Hastanesi, Centre Francois Baclesse, Hopital Bretonneau, Queen Elizabeth Hospital – Hong Kong, and other centers), bringing the total locations to 751. Several previously listed sites have been removed.
    Difference
    0.3%
    Check dated 2025-12-08T19:29:06.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added numerous new trial locations and investigators, expanding the study to 749 locations (e.g., Padua, New Delhi, München, Vienna, Buenos Aires, Port Macquarie, Mysore, Indira Gandhi Institute of Medical Sciences). Several previously listed sites were removed (e.g., Beijing Cancer Hospital, Fujian Cancer Hospital, Guangzhou sites).
    Difference
    1%
    Check dated 2025-12-01T15:50:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Liuchow, Guangxi, China (545006) as a study location and removed Liuzhou, Guangxi, China (545006); revision updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T10:51:37.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    - Added new study locations (e.g., Athens General Hospital 'Alexandra', Marathwada Cancer Hospital & Research Institute, Health New Zealand - Te Whatu Ora - MidCentral) and increased total locations to 742. - Several existing sites were removed, resulting in a net increase of 1 location.
    Difference
    0.2%
    Check dated 2025-11-16T19:49:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added recruitment sites Icon Cancer Centre (Australia) with Abhishek Joshi (Site 007-1003) and phone +61742266514; University General Hospital of Heraklion (PAGNI) with Dimitrios Mavroudis (Site 007-238) and phone 2810392750; Henry Dunant Hospital Center with Giannis Mountzios (Site 007-502) and phone 302107470960; Ege University Hospital (Izmir) with Tuncay Göksel (Site 007-060) and phone +902323434343+905322. Removed Local Institutions 007-1003, 007-238, 007-502, and 007-060 and their site/phone entries.
    Difference
    0.1%
    Check dated 2025-11-09T16:53:19.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added multiple new sites and investigators (including Istanbul, Larissa, Montpellier, Ulm) with updated recruitment statuses and contact details, bringing the total locations to 741. Removed several existing sites/locations (e.g., 007-024-Ph3; 007-2219; 007-235; 007-237; 007-044; 007-251; 007-642) and related entries.
    Difference
    0.2%
    Check dated 2025-11-01T08:22:16.000Z thumbnail image

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.